Accelerating Breakthrough Discoveries into Medicines

Our Approach

From Research Institutions to Patients

BioMotiv accelerates breakthrough discoveries into medicines through a unique business platform that brings pharmaceutical expertise, aligned capital, and industry partners together to support inventors and portfolio companies.


What We Do


Launch companies based on promising breakthrough discoveries from leading scientists and institutions.

arrow wide.png

Advance our  companies' technologies to clinical studies.

Handshake wide.png

Partner our portfolio companies for continued development and commercialization.

See Our Portfolio

What We Provide

light bulb.png

Pharmaceutical Expertise

Our leadership and portfolio teams are well-versed in translational science having supported numerous programs into clinical development and to the marketplace. 

Meet Our Team



BioMotiv provides the lead investment and actively secures additional funds to advance our portfolio companies.


Industry Partnerships

We have established strategic partnerships with Takeda, Biogen, Arix Bioscience, and Charles River Laboratories to support technology development and commercialization.

Read more about Our Strategic Partnerships

Artboard 1.png

Broad Business Networks

We have deep relationships in the investment and pharmaceutical industries that are accessed for the benefit of BioMotiv portfolio companies.


Efficient Operating Platform

BioMotiv provides an operating platform including business development, legal, financial, and administrative support to enable companies to focus their resources on their programs.